IFP Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

IFP Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20	Closed	-$1.95K	–	3278
2021 Q1	$2K	Sell	20 -28	-58%	-$2.84K	﹤0.01%	2732
2020 Q4	$4K	Buy	+48	New	+$4.09K	﹤0.01%	2445
2018 Q2	–	Sell	-13	Closed	-$2K	–	4093
2018 Q1	$2K	Hold	13	–	–	﹤0.01%	3559
2017 Q4	$2K	Hold	13	–	–	﹤0.01%	3610
2017 Q3	$1K	Hold	13	–	–	﹤0.01%	3974
2017 Q2	$2K	Hold	13	–	–	﹤0.01%	3787
2017 Q1	$2K	Hold	13	–	–	﹤0.01%	3712
2016 Q4	$1K	Hold	13	–	–	﹤0.01%	3867
2016 Q3	$1K	Hold	13	–	–	﹤0.01%	3795
2016 Q2	$1K	Buy	+13	New	+$1.3K	﹤0.01%	3710

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

IFP Advisors's VBIV Position: Q2 2021 in Review

IFP Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2021, closing a stake of 20 shares — an estimated $1.95K sold.

IFP Advisors first reported a position in VBIV in Q2 2016 and held it in 10 quarters. The position peaked at $4K in Q4 2020. 134 funds tracked by Wall St. Rank hold VBIV as of Q2 2021.

IFP Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2021 after selling out during the quarter.
IFP Advisors sold 20 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2021, an estimated $1.95K.
IFP Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2016 and held it in 10 quarters.
IFP Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $4K in Q4 2020.
134 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2021.

Based on IFP Advisors's 13F filing for Q2 2021, filed 13 Jul 2021.